Autoimmune conditions are rising and costing the UK over £13 billion each year, a report launched today has revealed. Connect Immune Research, a group of medical research charities, issued the report to highlight the need for greater recognition and investment for autoimmune conditions as a distinct research area, alongside the likes of cancer, infectious disease and dementia.
A group of medical research charities has launched a first-of-its-kind research project to confront the UK’s high prevalence of autoimmune conditions.
Our response to a survey from the Francis Crick Institute indicating that a hard Brexit could 'cripple UK science'
Our response to news that the Nobel Prize for Medicine or Physiology 2018 has been awarded to James P Allison and Tasuku Honjo for their work on cancer and the immune system.
Our response to the publication of the NHS Immunisation Statistics, England 2017-18
Our response to news that measles cases in Europe have soared in the first six months of this year
The Department of Health and Social Care have announced that adolescent boys in England will routinely be given the HPV vaccine.
Our response to the JCVI's statement on whether adolescent boys should receive the HPV vaccine.
On the tenth anniversary of the United Kingdom Primary Immunodeficiency (UKPID) Registry, the publication of their Primary Immunodeficiency (PID) report offers the most comprehensive view to date of this small but significant group of UK patients. This report, published in Clinical & Experimental Immunology, provides valuable information on PID in the UK, especially regarding delays to diagnosis. The longer it takes for a patient to be diagnosed, the less well the patient may do in the long-term, so this information is key in helping patients in the future.
Shillitoe et al. 2018 The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clinical & Experimental Immunology https://doi.org/10.1111/cei.13125
Our response to a paper in Nature Reviews Cancer on the environmental factors associated with the development of acute lymphoblastic leukaemia.
Our response to new research on a molecule to target the common cold virus
BSI statement into response to the Cochrane review on the safety and effectiveness of the HPV vaccine
Our response to paper on fish oil and probiotic supplements during pregnancy reducing the risk of food allergies and eczema in children.
Our response to news stories on a new vaccine-based immunotherapy to treat grass pollen allergy
Our response to a paper published in Science on a new approach to develop a universal flu vaccine